Symptoms, unmet need, and quality of life among recent breast cancer survivors

Journal of Community and Supportive Oncology

Volumn 14, Issue 7, 2016, Pages 299-306

  Palmer, Steven C ^a   Demichele, Angela ^a   Schapira, Marilyn ^a   Glanz, Karen ^a   Blauch, Abigail N ^a   Pucci, Donna A ^a   Jacobs, Linda A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTHRALGIA; ARTICLE; CANCER FATIGUE; CANCER STAGING; CANCER SURVIVOR; CROSS-SECTIONAL STUDY; FEMALE; HOT FLUSH; HUMAN; INSOMNIA; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MIDDLE AGED; QUALITY OF LIFE; SHORT FORM 12; SYMPTOM ASSESSMENT;

EID: 84982839331     PISSN: 23307749     EISSN: None     Source Type: Journal    
DOI: 10.12788/jcso.0236     Document Type: Article

References (35)

1. Cancer Facts & Figures 2015. http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf. Released 2015. Accessed July 1, 2016.
2. Kenyon M, Mayer DK, Owens AK. Late and long- Term effects of breast cancer treatment and surveillance management for the general practitioner. J Obstet Gynecol Neonatal Nurs. 2014;43:382-398.
3. Matro JM, Goldstein LJ. How do I follow patients with early breast cancer after completing adjuvant therapy. Curr Treat Options Oncol. 2014;15:63-78.
4. Hill DA, Horick NK, Isaacs C, et al. Long- Term risk of medical conditions associated with breast cancer treatment. Breast Cancer Res Treat. 2014;145:233-243.
5. Janz NK, Mujahid M, Chung LK, et al. Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt). 2007;16:1348-1361.
6. Fu OS, Crew KD, Jacobson JS, et al. Ethnicity and persistent symptom burden in breast cancer survivors. J Cancer Surviv. 2009;3:241-250.
7. Cheng KK, Darshini Devi R, Wong WH, Koh C. Perceived symptoms and the supportive care needs of breast cancer survivors six months to five years post- Treatment period. Eur J Oncol Nurs. 2014;18:3-9.
8. Patrick DL, Ferketich SL, Frame PS, et al. National Institutes of Health state-of- The-science conference statement: symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst. 2003;95:1110-1117.
9. Basch E, Iasonos A, McDonough T, et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: Results of a questionnaire based study. Lancet Oncol. 2006;7:903-909.
10. Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol. 2004;22:3485-3490.
11. Sneeuw KC, Sprangers MA, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol. 2002;55:1130-1143.
12. Litwin MS, Lubeck DP, Henning JM, Carroll PR. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database. J Urol. Jun 1998;159:1988-1992.
13. Houts PS, Yasko JM, Kahn SB, Schelzel GW, Marconi KM. Unmet psychological, social, and economic needs of persons with cancer in Pennsylvania. Cancer. 1986;58:2355-2361.
14. Barg FK, Cronholm PF, Straton JB, et al. Unmet psychosocial needs of Pennsylvanians with cancer: 1986-2005. Cancer. 2007;110:631-639.
15. Kidwell KM, Harte SE, Hayes DF, et al. Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy. Cancer. 2014;120:2403-2411.
16. Osse BH, Vernooij-Dassen MJ, Schade E, Grol RP. The problems experienced by patients with cancer and their needs for palliative care. Support Care Cancer. 2005;13:722-732.
17. Akechi T, Uchida M, Nakaguchi T, et al. Difference of patient's perceived need in breast cancer patients after diagnosis. Jpn J Clin Oncol. 2015;45:75-80.
18. Basch E, Iasonos A, Barz A, et al. Long- Term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol. 2007;25:5374-5380.
19. Ware J Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
20. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
21. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17:857-872.
22. Archer J, Bower P, Gilbody S, et al. Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev. 2012;10:CD006525.
23. Jassim GA, Whitford DL, Hickey A, Carter B. Psychological interventions for women with non-metastatic breast cancer. Cochrane Database Syst Rev. 2015;5:CD008729.
24. Gallicchio L, MacDonald R, Wood B, Rushovich E, Helzlsouer KJ. Menopausal- Type symptoms among breast cancer patients on aromatase inhibitor therapy. Climacteric. 2012;15:339-349.
25. Park JH, Bae SH, Jung YS, Kim KS. Quality of life and symptom experience in breast cancer survivors after participating in a psychoeducational support program: A pilot study. Cancer Nurs. 2012;35:E34-E41.
26. Henry NL, Clauw DJ. Thinking beyond the tumor to better understand chronic symptoms in breast cancer survivors. Breast Cancer Res Treat. 2012;133:413-416.
27. Cella D, Fallowfield LJ. Recognition and management of treatment related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat. 2008;107:167-180.
28. Hershman DL, Shao T, Kushi LH, et al. Early discontinuation and non- Adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. Apr 2011;126:529-537.
29. Boonstra A, van Zadelhoff J, Timmer-Bonte A, Ottevanger PB, Beurskens CH, van Laarhoven HW. Arthralgia during aromatase inhibitor treatment in early breast cancer patients: prevalence, impact, and recognition by healthcare providers. Cancer Nurs. 2013;36:52-59.
30. Ganz PA. Breast cancer, menopause, and long- Term survivorship: critical issues for the 21st century. Am J Med. 2005;118(suppl 12B):136-141.
31. Schmitz KH, Neuhouser ML, Agurs-Collins T, et al. Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst. 2013;105:1344-1354.
32. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta- Analysis. Breast Cancer Res Treat. 2010;123:627-635.
33. Irwin ML, Cartmel B, Gross CP, et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol. 2015;33:1104-1111.
34. Byar KL, Berger AM, Bakken SL, Cetak MA. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum. 2006;33:E18-E26.
35. Kenefick AL. Patterns of symptom distress in older women after surgical treatment for breast cancer. Oncol Nurs Forum. 2006;33:327-335.